Market Cap (In INR)
311.12 Billion
Revenue (In INR)
10.51 Billion
Net Income (In INR)
3 Billion
Avg. Volume
580.03 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 585.2-1360.0
- PE
- -
- EPS
- -
- Beta Value
- 1.338
- ISIN
- INE03QK01018
- CUSIP
- Y831GW103
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Sudhir Kumar Singh Ph.D.
- Employee Count
- -
- Website
- https://www.suvenpharm.com
- Ipo Date
- 2020-03-09
- Details
- Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
More Stocks
-
NLLSFNel ASA
NLLSF
-
PLNKPlank Ventures Ltd.
PLNK
-
BGOPFBango PLC
BGOPF
-
6947Zuken Inc.
6947
-
GLGI
-
AKASH
-
XAIRBeyond Air, Inc.
XAIR
-
688335